Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Seto

Showing results (141-150 of 242) with videos related to

Pageof 25
Sort By:
Lung Cancer (Amsterdam, Netherlands)|July 2, 2011
Signet ring cell adenocarcinoma of the lung with an EML4-ALK fusion gene mimicking mucinous (colloid) adenocarcinoma: a case reportTaro Ohba, Kenji Sugio, Takuro Kometani, et al.
Thoracic Cancer|November 25, 2016
Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1*28 or *6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A)Minoru Fukuda, Midori Shimada, Takeshi Kitazaki, et al.
Anticancer Research|July 2, 2014
Non-small cell lung cancer patients with EML4-ALK fusion gene are insensitive to cytotoxic chemotherapyYosuke Morodomi, Mitsuhiro Takenoyama, Eiko Inamasu, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Randomized phase II trial of weekly dose-intensive chemotherapy or amrubicin plus cisplatin chemotherapy following induction chemoradiotherapy for limited-disease small cell lung cancer (JCOG1011)Ikuo Sekine, Hideyuki Harada, Noboru Yamamoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 11, 2011
Phase I clinical study of the angiogenesis inhibitor TSU-68 combined with carboplatin and paclitaxel in chemotherapy-naive patients with advanced non-small cell lung cancerIsamu Okamoto, Hiroshige Yoshioka, Koji Takeda, et al.
Lung Cancer (Amsterdam, Netherlands)|June 22, 2013
An extremely rare case of small-cell lung cancer harboring variant 2 of the EML4-ALK fusion geneGouji Toyokawa, Mitsuhiro Takenoyama, Kenichi Taguchi, et al.
Cancer Chemotherapy and Pharmacology|March 3, 2016
Safety and tolerability of AZD5363 in Japanese patients with advanced solid tumorsKenji Tamura, Jun Hashimoto, Yuko Tanabe, et al.
Clinical Lung Cancer|March 10, 2017
The Controlling Nutritional Status Score Is a Significant Independent Predictor of Poor Prognosis in Patients With Malignant Pleural MesotheliomaShinkichi Takamori, Gouji Toyokawa, Kenichi Taguchi, et al.
Thoracic Cancer|February 6, 2020
S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Study protocol of LOGIK1605/JART-1501Minoru Fukuda, Soichiro Funaki, Takuya Yamazaki, et al.
Thoracic Cancer|July 8, 2016
Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B)Minoru Fukuda, Takayuki Suetsugu, Midori Shimada, et al.
Pageof 25

Showing results (141-150 of 242) with videos related to

Sort By:
Pageof 25
Lung Cancer (Amsterdam, Netherlands)|July 2, 2011
Signet ring cell adenocarcinoma of the lung with an EML4-ALK fusion gene mimicking mucinous (colloid) adenocarcinoma: a case reportTaro Ohba, Kenji Sugio, Takuro Kometani, et al.
Thoracic Cancer|November 25, 2016
Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1*28 or *6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A)Minoru Fukuda, Midori Shimada, Takeshi Kitazaki, et al.
Anticancer Research|July 2, 2014
Non-small cell lung cancer patients with EML4-ALK fusion gene are insensitive to cytotoxic chemotherapyYosuke Morodomi, Mitsuhiro Takenoyama, Eiko Inamasu, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Randomized phase II trial of weekly dose-intensive chemotherapy or amrubicin plus cisplatin chemotherapy following induction chemoradiotherapy for limited-disease small cell lung cancer (JCOG1011)Ikuo Sekine, Hideyuki Harada, Noboru Yamamoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 11, 2011
Phase I clinical study of the angiogenesis inhibitor TSU-68 combined with carboplatin and paclitaxel in chemotherapy-naive patients with advanced non-small cell lung cancerIsamu Okamoto, Hiroshige Yoshioka, Koji Takeda, et al.
Lung Cancer (Amsterdam, Netherlands)|June 22, 2013
An extremely rare case of small-cell lung cancer harboring variant 2 of the EML4-ALK fusion geneGouji Toyokawa, Mitsuhiro Takenoyama, Kenichi Taguchi, et al.
Cancer Chemotherapy and Pharmacology|March 3, 2016
Safety and tolerability of AZD5363 in Japanese patients with advanced solid tumorsKenji Tamura, Jun Hashimoto, Yuko Tanabe, et al.
Clinical Lung Cancer|March 10, 2017
The Controlling Nutritional Status Score Is a Significant Independent Predictor of Poor Prognosis in Patients With Malignant Pleural MesotheliomaShinkichi Takamori, Gouji Toyokawa, Kenichi Taguchi, et al.
Thoracic Cancer|February 6, 2020
S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Study protocol of LOGIK1605/JART-1501Minoru Fukuda, Soichiro Funaki, Takuya Yamazaki, et al.
Thoracic Cancer|July 8, 2016
Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B)Minoru Fukuda, Takayuki Suetsugu, Midori Shimada, et al.
Pageof 25